These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 9123594)
1. Soluble complement receptor type 1 and antithrombin-III combination therapy prolongs xenograft survival: the role of thrombin and prostacyclin in hyperacute rejection. Fujiwara I; Nakajima H; Akioka K; Matsuda T; Oka T Transplant Proc; 1997; 29(1-2):935-7. PubMed ID: 9123594 [No Abstract] [Full Text] [Related]
2. Prolongation of xenograft survival by soluble complement receptor type 1 and antithrombin-III combination therapy. Fujiwara I; Nakajima H; Arakawa K; Akioka K; Takeshita K; Oka T Transplant Proc; 1996 Apr; 28(2):685-6. PubMed ID: 8623345 [No Abstract] [Full Text] [Related]
3. The anticoagulant effect of antithrombin III on hyperacute xenograft rejection. Takeshita K; Arakawa K; Okamoto M; Akioka K; Fujiwara I; Kobayashi K; Imanishi J; Oka T Transplant Proc; 1996 Apr; 28(2):631-2. PubMed ID: 8623314 [No Abstract] [Full Text] [Related]
4. Allogeneic heart transplantation following xenografting. Pratschke J; Breuer M; Hammer C; Schütz A; Kemkes BM; Engelhardt M; Brandl U; Saumweber D; Babic R; Reichart B Transplant Proc; 1992 Apr; 24(2):688-90. PubMed ID: 1566482 [No Abstract] [Full Text] [Related]